Brookline, MA, United States of America

Anupriya Dutta

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Evelo Biosciences, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anupriya Dutta. Retrieved from https://idiyas.com/inventor/anupriya-dutta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anupriya Dutta: Innovator in Cancer Treatment

Introduction

Anupriya Dutta is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.

Latest Patents

Anupriya Dutta holds a patent for "Compositions and methods of treating cancer using ssp." This patent outlines methods and compositions related to ssp, which are useful as therapeutic agents in the fight against cancer. He has 1 patent to his name.

Career Highlights

Anupriya Dutta is currently employed at Evelo Biosciences, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing new treatment options that could potentially improve patient outcomes.

Collaborations

Anupriya collaborates with talented professionals in his field, including Peter Sandy and Jacqueline Papkoff, who contribute to the innovative environment at Evelo Biosciences, Inc.

Conclusion

Anupriya Dutta's work in cancer treatment exemplifies the impact of innovation in medicine. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…